Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 1, 2000, Pages 258-263

  Takahashi, Hiroki ^a,b,c   Kuroki, Yoshio ^a,b,c   Tanaka, Hiroshi ^a,b,c   Saito, Tsukasa ^a,b,c   Kurokawa, Keizo ^a,b,c   Chiba, Hirofumi ^a,b,c   Sagawa, Akira ^a,b,c   Nagae, Hisato ^a,b,c   Abe, Shosaku ^a,b,c  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sapporo Yamanoue Hospital   (Japan)

^c YAMASA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC SCLEROSIS;

EID: 0033925457     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.1.9903014     Document Type: Article

References (36)

1. 1. Schurawitzki, H., R. Stiglbauer, W. Graninger, C. Herold, D. Polzleitner, O. C. Burghuber, and D. Tscholakoff. 1990. Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology 176:755-759.
2. 2. Steen, V. D., G. R. Owens, G. J. Fino, G. P. Rodnan, and T. A. Medsger, Jr. 1985. Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis Rheum. 28:759-767.
3. 3. Bianchi, F. A., A. R. Bistue, V. E. Wendt, H. E. Puro, and M. K. Keech. 1966. Analysis of twenty-seven cases of progressive systemic sclerosis (including two with combined systemic lupus erythematosus) and a review of the literature. J. Chronic Dis. 19:953-977.
4. 4. Thurlbeck, W. M., R. R. Miller, N. L. Muller, and E. C. Rosenow, III. 1990. Collagen Vascular Diseases: Diffuse Diseases of the Lung. Decker, Philadelphia. 139-148.
5. 5. Nishioka, K., I. Katayama, H. Kondo, H. Shinkai, H. Ueki, K. Tamaki, K. Takehara, S. Tajima, M. Maeda, S. Hayashi, H. Kodama, Y. Miyachi, H. Mizutani, A. Fujisaku, T. Sasaki, M. Shimizu, and J. Kaburagi. 1996. Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis (SSc): Scleroderma Research Committee Japan. J. Dermatol. 23:677-682.
6. 6. Medsger, T. A., Jr., A. T. Masi, G. P. Rodnan, T. G. Benedek, and H. Robinson. 1971. Survival with systemic sclerosis (scleroderma). Ann. Intern. Med. 75:369-376.
7. 7. Steen, V. D., J. K. Lanz, Jr., C. Conte, G. R. Owens, and T. A. Medsger, Jr. 1994. Therapy for severe interstitial lung disease in systemic sclerosis: a retrospective study. Arthritis Rheum. 37:1290-1296.
8. 8. Day, A. J. 1994. The C-type carbohydrate recognition domain (CRD) superfamily. Biochem. Soc. Trans. 22:83-88.
9. 9. Walker, S. R., M. C. Williams, and B. Benson. 1986. Immunocytochemical localization of the major surfactant apoprotein in type II cells, Clara cells and alveolar macrophages of rat lung. J. Histochem. Cytochem. 34:1137-1148.
10. 10. Voorhout, W. F., T. Veenendaal, Y. Kuroki, Y. Ogasawara, L. M. G. van Golde, and H. J. Geuze. 1992. Immunocytochemical localization of surfactant protein (SP-D) in type II cells, Clara cells, and alveolar macrophages of rat lungs. J. Histochem. Cytochem. 40:1589-1597.
11. 11. Kuroki, Y., Y. Fukada, H. Takahashi, and T. Akino. 1985. Monoclonal antibodies against human pulmonary surfactant apoproteins: specificity and application in immunoassay. Biochim. Biophys. Acta 836:201-209.
12. 12. Kuroki, Y., S. Tsutahara, N. Shijubo, H. Takahashi, M. Shiratori, A. Hattori, Y. Honda, S. Abe, and T. Akino. 1993. Elevated levels of lung surfactant protein A in sera from patients with idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis. Am. Rev. Respir. Dis. 147:723-729.
13. 13. Honda, Y., Y. Kuroki, N. Shijubo, T. Fujishima, T. Takahashi, K. Hosoda, T. Akino, and S. Abe. 1995. Aberrant appearance of lung surfactant protein A in sera of patients with idiopathic pulmonary fibrosis and its clinical significance. Respiration 62:64-69.
14. 14. Takahashi, H., Y. Honda, Y. Kuroki, K. Imai, and S. Abe. 1995. Pulmonary surfactant protein A: a serum marker of pulmonary fibrosis in patients with collagen vascular diseases. Clin. Chim. Acta 239:213-215.
15. 15. Honda, Y., Y. Kuroki, E. Matuura, H. Nagae, H. Takahashi, T. Akino, and S. Abe. 1995. Pulmonary surfactant protein D in sera and broncho-alveolar lavage fluids. Am. J. Respir. Crit. Care Med. 152:1860-1866.
16. 16. Hansell, D. M., and I. H. Kerr. 1991. The role of high resolution computed tomography in the diagnosis of interstitial lung disease. Thorax 46:77-84.
17. 17. Muller, N. L., and R. R. Miller. 1990. Computed tomography of chronic diffuse infiltrative lung disease: part 1. Am. Rev. Respir. Dis. 142:1206-1215.
18. 18. Towbin, H., T. Staehelin, and J. Gorden. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheet: procedures and some applications. Proc. Natl. Acad. Sci. U.S.A. 76:4350-4353.
19. 19. Inoue, T., E. Matsuura, A. Nagata, Y. Ogasawara, A. Hattori, Y. Kuroki, S. Fujimoto, and T. Akino. 1994. Enzyme-linked immunosorbent assay for human pulmonary surfactant protein D. J. Immunol. Methods 173:157-164.
20. 20. Shimizu, H., K. Hosoda, M. Mizumoto, Y. Kuroki, H. Sato, K. Kataoka, M. Hagisawa, S. Fujimoto, and T. Akino. 1989. Improved immunoassay for the determination of surfactant protein A (SP-A). Tohoku J. Exp. Med. 157:269-278.
21. 2 fragment for the detection of human pulmonary surfactant D in sera. Clin. Chim. Acta 266:157-171.
22. 22. Hunninghake, G. W., and A. S. Fauci. 1979. Pulmonary involvement in the collagen vascular diseases. Am. Rev. Respir. Dis. 119:471-503.
23. 23. Yousem, S. A. 1990. The pulmonary pathologic manifestations of the CREST syndrome. Hum. Pathol. 21:467-474.
24. 24. Silver, R. M., K. S. Miller, M. B. Kinsella, E. A. Smith, and S. I. Schabel. 1990. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Am. J. Med. 88:470-476.
25. 25. Miller, K. S., E. A. Smith, M. Kinsella, S. I. Schabel, and R. M. Silver. 1990. Lung disease associated with progressive systemic sclerosis: assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity. Am. Rev. Respir. Dis. 141:301-306.
26. 26. van Krugten, M., N. A. Cobben, R. J. Lamers, M. P. van Dieijen-Visser, S. S. Wagenaar, E. F. Wouters, and M. Drent. 1996. Serum LDH: a marker of disease activity and its response to therapy in idiopathic pulmonary fibrosis. Neth. J. Med. 48:220-223.
27. 27. Matusiewicz, S. P., I. J. Williamson, P. J. Sime, P. H. Brown, P. R. Wenham, G. K. Crompton, and A. P. Greening. 1993. Plasma lactate dehydrogenase: a marker of disease activity in cryptogenic fibrosing alveolitis and extrinsic allergic alveolitis? Eur. Respir. J. 6:1282-1286.
28. 28. Weaver, T. E. 1998. Synthesis, processing and secretion of surfactant protein B and C. Biochim. Biophys. Acta 1408:173-179.
29. 29. Rubio, S., T. Lacaze-Masmonteil, B. Chailley-Heu, A. Kahn, R. J. Bourbon, and R. Ducroc. 1995. Pulmonary surfactant A (SP-A) is expressed by epithelial cells of small and large intestine. J. Biol. Chem. 270:12162-12169.
30. 30. Fisher, J. H., and R. J. Mason. 1995. Expression of pulmonary surfactant protein D in rat gastric mucosa. Am. J. Respir. Cell Mol. Biol. 12:13-18.
31. 31. Motwani, M., R. A. White, N. Guo, L. L. Dowler, A. I. Tauber, and K. N. Sastry. 1995. Mouse surfactant protein-D: cDNA cloning, characterization, and gene localization to chromosome 14. J. Immunol. 155:5671-5677.
32. 32. Kuroki, Y., H. Takahashi, H. Chiba, and T. Akino. 1998. Surfactant protein A and D: disease markers. Biochim. Biophys. Acta 1408:334-345.
33. 33. Harrison, N. K., A. R. Myers, B. Corrin, G. Soosay, A. Dewar, C. M. Black, R. M. DuBois, and M. Turner-Warwick. 1991. Structural features of interstitial lung disease in systemic sclerosis. Am. Rev. Respir. Dis. 144:706-713.
34. 34. Harrison, N. K., A. R. Glanville, B. Strickland, P. L. Haslam, B. Corrin, B. J. Addis, R. Lawrence, A. B. Millar, C. M. Black, and M. Turner-Warwick. 1989. Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance. Respir. Med. 83:403-414.
35. 35. Wells, A. U., D. M. Hansell, N. K. Harrison, R. Lawrence, C. M. Black, and R. M. duBois. 1993. Clearance of inhaled 99mTc-DTPA predicts the clinical coure of fibrosing alveolitis. Eur. Respir. J. 6:797-802.
36. 36. McCormack, F. X., T. E. King, Jr., D. R. Voelker, P. C. Robinson, and R. J. Mason. 1991. Idiopathic pulmonary fibrosis: abnormalities in the bronchoalveolar lavage content of surfactant protein A. Am. Rev. Respir. Dis. 144:160-166.